Proteomic analysis of frozen tissue samples using laser capture microdissection

Methods in Molecular Biology

Volumn 1002, Issue , 2013, Pages 71-83

  Mukherjee, Sumana ^a   Rodriguez Canales, Jaime ^a   Hanson, Jeffrey ^a   Emmert Buck, Michael R ^a   Tangrea, Michael A ^a   Prieto, Darue A ^b   Blonder, Josip ^b   Johann Jr , Donald J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

Author keywords

Biomarker; Cancer; Frozen tissue; Laser capture microdissection (LCM); Liquid chromatography mass spectrometry (LC MS); Solid tumor heterogeneity

Indexed keywords

PROTEOME; TUMOR MARKER;

BIODEGRADATION; CANCER PATIENT; CELL POPULATION; DATA BASE; FROZEN SECTION; HUMAN; LASER CAPTURE MICRODISSECTION; MASS SPECTROMETRY; MOLECULAR DIAGNOSTICS; PHYSICAL DISEASE BY BODY FUNCTION; PRESERVATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; REVIEW; SEQUENCE ANALYSIS; SOLID TUMOR; TUMOR MICROENVIRONMENT;

CELL SEPARATION; FROZEN SECTIONS; HUMANS; LASER CAPTURE MICRODISSECTION; MASS SPECTROMETRY; NEOPLASMS; PROTEINS; PROTEOME; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 84892760674     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-360-2_6     Document Type: Review

References (25)

1. Chen R, Mias GI, Li-Pook-Than J et al (2012) Personal omics pro fi ling reveals dynamic molecular and medical phenotypes. Cell 148:1293-1307
2. Zhan F, Huang Y, Colla S et al (2006) The molecular classi fi cation of multiple myeloma. Blood 108:2020-2028
3. Zhan F, Hardin J, Kordsmeier B et al (2002) Global gene expression pro fi ling of multiple myeloma, monoclonal gammopathy of undetermined signi fi cance, and normal bone marrow plasma cells. Blood 99:1745-1757
4. Zhou Y, Zhang Q, Stephens O et al (2012) Prediction of cytogenetic abnormalities with gene expression pro fi les. Blood 119:e148-e150
5. Emmert-Buck MR, Bonner RF, Smith PD et al (1996) Laser capture microdissection. Science 274:998-1001
6. Yachida S, Jones S, Bozic I et al (2010) Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467: 1114-1117
7. Gerlinger M, Rowan AJ, Horswell S et al (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883-892
8. Longo DL (2012) Tumor heterogeneity and personalized medicine. N Engl J Med 366:956-957
9. Mbeunkui F, Johann DJ Jr (2009) Cancer and the tumor microenvironment: a review of an essential relationship. Cancer Chemother Pharmacol 63:571-582
10. Swanton C, Caldas C (2009) Molecular classi fi cation of solid tumours: towards pathway- driven therapeutics. Br J Cancer 100: 1517-1522
11. Page MJ, Amess B, Townsend RR et al (1999) Proteomic de fi nition of normal human luminal and myoepithelial breast cells puri fi ed from reduction mammoplasties. Proc Natl Acad Sci USA 96:12589-12594
12. Ornstein DK, Gillespie JW, Paweletz CP et al (2000) Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis 21:2235-2242
13. Johann DJ Jr, Blonder J (2007) Biomarker discovery: tissues versus fl uids versus both. Expert Rev Mol Diagn 7:473-475
14. Johann DJ, Wei BR, Prieto DA et al (2010) Combined blood/tissue analysis for cancer biomarker discovery: application to renal cell carcinoma. Anal Chem 5:1584-1588
15. Wei BR, Simpson RM, Johann DJ et al (2012) Proteomic pro fi ling of H-Ras-G12V induced hypertrophic cardiomyopathy in transgenic mice using comparative LC-MS analysis of thin fresh-frozen tissue sections. J Proteome Res 11:1561-1570
16. Aebersold R, Mann M (2003) Mass spectrometry- based proteomics. Nature 422: 198-207
17. Hwang SI, Thumar J, Lundgren DH et al (2007) Direct cancer tissue proteomics: a method to identify candidate cancer biomarkers from formalin- fi xed paraf fi n-embedded archival tissues. Oncogene 26:65-76
18. Blonder J, Chan KC, Issaq HJ et al (2006) Identi fi cation of membrane proteins from mammalian cell/tissue using methanol-facilitated solubilization and tryptic digestion coupled with 2D-LC-MS/MS. Nat Protoc 1:2784-2790
19. Johann DJ, Rodriguez-Canales J, Mukherjee S et al (2009) Approaching solid tumor heterogeneity on a cellular basis by tissue proteomics using laser capture microdissection and biological mass spectrometry. J Proteome Res 8: 2310-2318
20. Hewitt SM, Badve SS, True LD (2012) Impact of preanalytic factors on the design and application of integral biomarkers for directing patient therapy. Clin Cancer Res 18: 1524-1530
21. Wang H, Qian WJ, Mottaz HM et al (2005) Development and evaluation of a microand nanoscale proteomic sample preparation method. J Proteome Res 4: 2397-2403
22. Peng J, Elias JE, Thoreen CC et al (2003) Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. J Proteome Res 2:43-50
23. Cha S, Imielinski MB, Rejtar T et al (2010) In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology. Mol Cell Proteomics 9:2529-2544
24. Luo Q, Yue G, Valaskovic GA et al (2007) On-line 1D and 2D porous layer open tubular/LC-ESI-MS using 10-microm-i.d. poly(styrene-divinylbenzene) columns for ultrasensitive proteomic analysis. Anal Chem 79:6174-6181
25. Thakur D, Rejtar T, Wang D et al (2011) Microproteomic analysis of 10,000 laser captured microdissected breast tumor cells using short-range sodium dodecyl sulfate-polyacrylamide gel electrophoresis and porous layer open tubular liquid chromatography tandem mass spectrometry. J Chromatogr A 1218: 8168-8174